Develops diagnostic systems to reduce the cost and improve the efficacy of personalised medical treatments
Biocartis has raised €323M across 9 funding rounds from 3 investors, most recently a round in Apr 2017. Based in Lausanne, Switzerland; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2017-04-01 | Other | €80M | — | View deal → |
| 2014-09-01 | Series D+ | €65M | — | View deal → |
| 2014-06-01 | Grant | €1.7M | — | View deal → |
| 2013-11-01 | Series D+ | €30M | — | View deal → |
| 2013-06-01 | Grant | €1.8M | — | View deal → |
| 2012-12-01 | Series D+ | €35M | — | View deal → |
| 2011-11-01 | Series C | €71M | — | View deal → |
| 2010-04-01 | Series B | €30M | Advent Venture Partners,Aescap,Offshore Investment | View deal → |
| 2009-10-01 | Series A | €10M | Advent Venture Partners,Aescap | View deal → |
